Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liuzzi

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 23, 2008
Heart rate behavior during an exercise stress test in obese patientsL A Gondoni, A M Titon, F Nibbio, et al.
Brain Research|September 16, 1977
Gas chromatographic-mass spectrometric assay of serotonin in rat superior cervical ganglia. Effects of nerve growth factor and 6-hydroxydopamineA Liuzzi, F H Foppen, J M Saavedra, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1974
Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administrationA Liuzzi, P G Chiodini, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese femalesG Ferretti, T Bacchetti, C Moroni, et al.
Clinical Endocrinology|September 21, 2006
Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndromeG Grugni, P Marzullo, L Ragusa, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1975
Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patientsP G Chiodini, A Liuzzi, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1982
Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemiaD Dallabonzana, B Spelta, L Botalla, et al.
Thyroid : Official Journal of the American Thyroid Association|December 1, 1995
Thyroperoxidase microsatellite polymorphism in thyroid diseasesM T Pirro, V De Filippis, A Di Cerbo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 3, 2003
Effect of chronic treatment with beta-blockers on resting energy expenditure in obese hypertensive patients during a low-calorie and physical training programL A Gondoni, M A Tagliaferri, A M Titon, et al.
Acta Endocrinologica|August 1, 1983
The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegalyS W Lamberts, J G Klijn, C C van Vroonhoven, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 23, 2008
Heart rate behavior during an exercise stress test in obese patientsL A Gondoni, A M Titon, F Nibbio, et al.
Brain Research|September 16, 1977
Gas chromatographic-mass spectrometric assay of serotonin in rat superior cervical ganglia. Effects of nerve growth factor and 6-hydroxydopamineA Liuzzi, F H Foppen, J M Saavedra, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1974
Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administrationA Liuzzi, P G Chiodini, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese femalesG Ferretti, T Bacchetti, C Moroni, et al.
Clinical Endocrinology|September 21, 2006
Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndromeG Grugni, P Marzullo, L Ragusa, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1975
Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patientsP G Chiodini, A Liuzzi, L Botalla, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1982
Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemiaD Dallabonzana, B Spelta, L Botalla, et al.
Thyroid : Official Journal of the American Thyroid Association|December 1, 1995
Thyroperoxidase microsatellite polymorphism in thyroid diseasesM T Pirro, V De Filippis, A Di Cerbo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 3, 2003
Effect of chronic treatment with beta-blockers on resting energy expenditure in obese hypertensive patients during a low-calorie and physical training programL A Gondoni, M A Tagliaferri, A M Titon, et al.
Acta Endocrinologica|August 1, 1983
The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegalyS W Lamberts, J G Klijn, C C van Vroonhoven, et al.
Pageof 13